CONMED Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by CONMED Corporation on January 6, 2026, with the earliest event reported on January 8, 2026. The filing addresses a significant change in executive leadership regarding the Chief Financial Officer.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and associated compensation arrangements rather than financial performance results.
Material Changes
- Executive Departure: Mr. Todd Garner, Chief Financial Officer (CFO), will separate from the Company effective on the earlier of March 15, 2026, or the appointment of a new permanent CFO.
- Transition Plan: Mr. Garner will remain employed through November 2, 2026, to ensure a smooth transition. An executive search firm has been retained to find a permanent replacement.
- Reason for Departure: The separation did not arise from any disagreement regarding operations, policies, financial results, or accounting practices.
Guidance, Outlook, and Compensation Details
The filing outlines the following compensatory arrangements under a Transition Letter Agreement and the Executive Severance Plan:
- Pre-Transition Period: Mr. Garner continues to receive current compensation and benefits, including eligibility for his 2025 annual bonus. He is not entitled to a 2026 annual equity award grant.
- Consulting Period (through Nov 2, 2026): Mr. Garner will receive his current base salary and remain eligible for a pro-rated 2026 annual cash bonus based on 2025 targets, subject to performance metrics and termination conditions.
- Equity Vesting: Outstanding equity awards will continue to vest through November 2, 2026, subject to continued employment and other conditions.
- Benefits: Eligibility to participate in employee benefit plans continues during the consulting period.
Investor Verification Checklist
- Verify the exact date of the CFO Transition Date (March 15, 2026, or earlier upon new appointment).
- Review the attached Exhibit 10.1 (Letter Agreement) for specific restrictive covenants and "Cause" definitions affecting bonus eligibility.
- Monitor subsequent filings for the announcement of the new permanent CFO.
- Confirm that no undisclosed disagreements regarding financial reporting exist, as stated in the filing.